Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect
- PMID: 2677960
Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect
Abstract
Indomethacin decreases cerebral blood flow velocity and blood flow in the preterm infant. The duration of this negative effect has not been established. Cerebral blood flow velocity was evaluated in 24 preterm infants with symptomatic patent ductus arteriosus before and during the first 12 hours after a single intravenous dose of indomethacin, 0.1 mg/kg. Cerebral blood flow velocity was estimated by serial Doppler investigations of the anterior cerebral arteries. Indomethacin administration led to an instantaneous decrease of peak systolic flow velocity, temporal mean flow velocity, and end-diastolic flow velocity of the anterior cerebral arteries in all infants, which was maximal between 2 and 40 minutes after indomethacin administration and was followed by a more sustained recovery of all velocities to baseline values. Temporal mean flow velocity was not different from pre-indomethacin values at 3 hours after the administration. It is concluded that indomethacin can impact the cerebral circulation of the preterm infant for at least 2 hours. This may have consequences in preterm infants with unstable hemodynamics and pulmonary function.
Comment in
-
Why use indomethacin?Pediatrics. 1990 Jul;86(1):146-7. Pediatrics. 1990. PMID: 2359675 No abstract available.
Similar articles
-
Regional cerebral blood flow velocity changes after indomethacin infusion in preterm infants.Arch Dis Child. 1992 Jul;67(7 Spec No):851-4. doi: 10.1136/adc.67.7_spec_no.851. Arch Dis Child. 1992. PMID: 1519988 Free PMC article.
-
Effect of indomethacin on superior mesenteric artery blood flow velocity in preterm infants.J Pediatr. 1990 Jun;116(6):965-70. doi: 10.1016/s0022-3476(05)80662-6. J Pediatr. 1990. PMID: 2112189
-
Abnormal cerebral hemodynamics in preterm infants with patent ductus arteriosus.Pediatrics. 1982 Jun;69(6):778-81. Pediatrics. 1982. PMID: 7079043
-
Cardiovascular adaptation in the very immature infant.Br Med Bull. 1988 Oct;44(4):1025-36. doi: 10.1093/oxfordjournals.bmb.a072287. Br Med Bull. 1988. PMID: 3076824 Review. No abstract available.
-
Cerebral glucose deficiency versus oxygen deficiency in neonatal encephalopathy.J Neonatal Perinatal Med. 2018;11(2):115-120. doi: 10.3233/NPM-17109. J Neonatal Perinatal Med. 2018. PMID: 29710737 Review.
Cited by
-
Near-infrared spectroscopy for detection of a significant patent ductus arteriosus.Pediatr Res. 2016 Nov;80(5):675-680. doi: 10.1038/pr.2016.148. Epub 2016 Sep 7. Pediatr Res. 2016. PMID: 27603562
-
Clinical considerations for the pharmacologic management of patent ductus arteriosus with cyclooxygenase inhibitors in premature infants.J Pediatr Pharmacol Ther. 2007 Jul;12(3):147-57. doi: 10.5863/1551-6776-12.3.147. J Pediatr Pharmacol Ther. 2007. PMID: 23055850 Free PMC article.
-
Effects of antenatal magnesium sulfate treatment for neonatal neuro-protection on cerebral oxygen kinetics.Pediatr Res. 2015 Sep;78(3):310-4. doi: 10.1038/pr.2015.96. Epub 2015 May 18. Pediatr Res. 2015. PMID: 25985294
-
Comparative tolerability of pharmacological treatments for patent ductus arteriosus.Drug Saf. 2001;24(7):537-51. doi: 10.2165/00002018-200124070-00005. Drug Saf. 2001. PMID: 11444725 Review.
-
The effect of dexamethasone on time averaged mean velocity in the middle cerebral artery in very low birth weight infants.Eur J Pediatr. 1994 May;153(5):363-6. doi: 10.1007/BF01956420. Eur J Pediatr. 1994. PMID: 7913442
MeSH terms
Substances
LinkOut - more resources
Medical